Broaden and Build Up Knowledge Based on Investigative and Clinical Research

키워드

참고문헌 (14)

1. Karl Erik Andersson, "On the Site and Mechanism of Action of β3-Adrenoceptor Agonists in the Bladder", International Neurourology Journal, 21(1), pp.6~11 (2017), 대한배뇨장애요실금학회
2. 조영삼, "Botulinum toxin in spinal cord injury patients with neurogenic detrusor overactivity", Journal of exercise rehabilitation, 12(6), pp.624~631 (2016), 한국운동재활학회
3. Abrams P, "The standardisation of terminology of lower urinary tract function : report from the Standardisation Sub-committee of the International Continence Society", Neurourol Urodyn, 21, pp.167~178 (2002)
4. Karel Dewulf, "Addressing challenges in underactive bladder: recommendations and insights from the Congress on Underactive Bladder (CURE-UAB)", International Urology and Nephrology, 49(5), pp.777~785 (2017), Springer Nature[DOI]
5. Nathan Hoag, "Underactive Bladder: Clinical Features, Urodynamic Parameters, and Treatment", International Neurourology Journal, 19(3), pp.185~189 (2015), 대한배뇨장애요실금학회
6. Elena E. Foditsch, "Structural Changes of the Urinary Bladder After Chronic Complete Spinal Cord Injury in Minipigs", International Neurourology Journal, 21(1), pp.12~19 (2017), 대한배뇨장애요실금학회
7. Tsuyoshi Hattori, "Ketanserin and Naftopidil Enhance the Potentiating Effect of Alpha-Methyl-Serotonin on the Neurally-Induced Contraction of Human Isolated Urinary Bladder Muscle Strips", International Neurourology Journal, 21(1), pp.20~28 (2017), 대한배뇨장애요실금학회
8. 김수진, "Evidence Is Enough?: A Systematic Review and Network Meta- Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients", International Neurourology Journal, 21(1), pp.29~37 (2017), 대한배뇨장애요실금학회
9. Dunn CJ, "Tamsulosin : a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms", Drugs Aging, 19, pp.135~161 (2002)
10. Kawabe K, "Use of an alpha 1-blocker, YM617, in the treatment of benign prostatic hypertrophy. YM617 Clinical Study Group", J Urol, 144, pp.908~911 (1990)
11. Shim SR, "General effect of low-dose tamsulosin (0.2 mg) as a first-line treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia:a systematic review and meta-analysis", Curr Med Res Opin, 31, pp.353~365 (2015)
12. Park CH, "Efficacy of low-dose tamsulosin on lower urinary tract symptoms suggestive of benign prostatic hyperplasia : a nonblind multicentre korean study", Clin Drug Investig, 24, pp.41~47 (2004)
13. 김신욱, "Effects of Low-Dose Tamsulosin on Sexual Function in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia", Investigative and Clinical Urology, 54(10), pp.697~702 (2013), 대한비뇨기과학회
14. Kim KS, "Efficacy of dose escalation of tamsulosin for the treatment in symptomatic benign prostatic hyperplasia of lower urinary tract symptoms:a randomised, double-blind, phase 3 trial in Korean men", J Urol, 195(4 Suppl), pp.e466~ (2016)

관련 논문AI추천